Lola Rahib

10.4k citations

36 papers · 7.0k indexed · 3 hit papers · h-index 17

Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research 22
- Global Cancer Incidence and Screening 4
Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 16
Pulmonary and Respiratory Medicine top 2%
- Renal cell carcinoma treatment 7
- Advanced Breast Cancer Therapies 2
Surgery top 2%
Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 6
- Peroxisome Proliferator-Activated Receptors 5
Physiology
- Adipose Tissue and Metabolism 4

Co-authors: Lynn M. Matrisian Julie Fleshman Benjamin D. Smith Allison Rosenzweig Mackenzie R. Wehner Kevin T. Nead Andrew Hendifar Michael J. Pishvaian
Cited by: Oncology Cancer Research Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology (10 papers)PLoS ONE (1 paper)Cancer Research (1 paper)
Partner nations: United States United Kingdom Australia

In The Last Decade

Lola Rahib

33 papers receiving 6.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Lola Rahib

Since Specialization

Citations

This map shows the geographic impact of Lola Rahib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lola Rahib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lola Rahib more than expected).

Fields of papers citing papers by Lola Rahib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lola Rahib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lola Rahib. The network helps show where Lola Rahib may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lola Rahib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lola Rahib Line = papers co-authored together Lola Rahib links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Factors Driving Pancreatic Cancer Survival Rates Pancreas ·Lola Rahib,Tara B. Coffin,Barbara Kenner	2025	4
2	Development of a core outcome set for recurrent acute and chronic pancreatitis: Results of a Delphi poll Pancreatology ·Lola Rahib,William Salerno,Maisam Abu‐El‐Haija,Darwin L. Conwell,A. Jay Freeman,Phil A. Hart,Stephen J. Pandol,Emily R. Perito,Dhiraj Yadav,Tonya M. Palermo	2024	0
3	Pre-Diagnosis Pain in Patients With Pancreatic Cancer Signals the Need for Aggressive Symptom Management The Oncologist ·Terry A. McNearney,Biai Dominique Elmir Digbeu,Jacques Baillargeon,Dennis Ladnier,Lola Rahib,Lynn M. Matrisian	2023	3
4	Extra-pancreatic manifestations reported in association with pancreatitis; an international survey report PLoS ONE ·Chinenye R. Dike,Qin Sun,Lola Rahib,Megan Golden,Maisam Abu‐El‐Haija	2023	2
5	The future landscape of cancer incidence and mortality until 2036 in the Russian Federation. Journal of Clinical Oncology ·Ilya Tsimafeyeu,Lola Rahib	2022	4
6	Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialbreakdown → The Lancet Oncology ·Michael J. Pishvaian,Edik M. Blais,Jonathan R. Brody,Emily E. Lyons,Patricia DeArbeloa,Andrew Hendifar,Sam Mikhail,Vincent Chung,Vaibhav Sahai,Davendra Sohal,Sara Bellakbira,Dzung Thach,Lola Rahib,Subha Madhavan,Lynn M. Matrisian,Emanuel F. Petricoin	2020	327
7	Use of a real-world data approach to rapidly generate outcomes data following a case study of a novel treatment combination in pancreatic adenocarcinoma. Journal of Clinical Oncology ·Lola Rahib,Karen Chen,Allyson J. Ocean,Changqing Xie,Austin G. Duffy,Gulam A. Manji,Tim F. Greten,Mark Shapiro,Jeff Shrager,William Hoos,Bryan Federowicz,Conan G. Kinsey	2020	3
8	Multi-omic molecular comparison of primary versus metastatic pancreatic tumours British Journal of Cancer ·Gagandeep Brar,Edik M. Blais,R Joseph Bender,Jonathan R. Brody,Davendra Sohal,Subha Madhavan,Vincent J. Picozzi,Andrew Hendifar,Vincent Chung,David Halverson,Sameh Mikhail,Lynn M. Matrisian,Lola Rahib,Emanuel Petricoin,Michael J. Pishvaian	2019	23
9	Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative Clinical Cancer Research ·Michael J. Pishvaian,R Joseph Bender,David Halverson,Lola Rahib,Andrew Hendifar,Sameh Mikhail,Vincent Chung,Vincent J. Picozzi,Davendra Sohal,Edik M. Blais,Kimberly Mason,Emily E. Lyons,Lynn M. Matrisian,Jonathan R. Brody,Subha Madhavan,Emanuel F. Petricoin	2018	149
10	Pancreas Cancer-Associated Weight Loss The Oncologist ·Andrew Hendifar,Maria Q. B. Petzel,Teresa A. Zimmers,Crystal S. Denlinger,Lynn M. Matrisian,Vincent J. Picozzi,Lola Rahib	2018	114
11	Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis Targeted Oncology ·William H. Isacoff,Howard A. Reber,Rudolph A. Bedford,William Hoos,Lola Rahib,Alexander Upfill‐Brown,Timothy R. Donahue,O. Joe Hines	2018	24
12	A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative Oncotarget ·Michael J. Pishvaian,R Joseph Bender,Lynn M. Matrisian,Lola Rahib,Andrew Hendifar,William Hoos,Sam Mikhail,Vincent Chung,Vincent J. Picozzi,Craig Heartwell,Kimberly Mason,Katelyn Varieur,Metasebia Aberra,Subha Madhavan,Emanuel Petricoin,Jonathan R. Brody	2016	49
13	Multi-Omic profiling (MoP) for patients (pts) with pancreatic cancer (PDA): Initial results of the Know Your Tumor (KYT) initiative. Journal of Clinical Oncology ·Michael J. Pishvaian,Jonathan R. Brody,Lynn M. Matrisian,Andrew Hendifar,Anitra Engebretson,William Hoos,Sameh Mikhail,Vincent Chung,Vincent J. Picozzi,Corinne Ramos,Craig Heartwell,Kimberly Mason,Katelyn Varieur,Lola Rahib,Emanuel F. Petricoin,Subha Madhavan	2016	2
14	Mathematical modeling of the insulin signal transduction pathway for prediction of insulin sensitivity from expression data Molecular Genetics and Metabolism ·Clark K. Ho,Lola Rahib,James C. Liao,Ganesh Sriram,Katrina M. Dipple	2014	12
15	Pancreatic Cancer Clinical Trials and Accrual in the United States Journal of Clinical Oncology ·William Hoos,Porsha M. James,Lola Rahib,Anitra W. Talley,Julie Fleshman,Lynn M. Matrisian	2013	48
16	Transcriptomic and network component analysis of glycerol kinase in skeletal muscle using a mouse model of glycerol kinase deficiency Molecular Genetics and Metabolism ·Lola Rahib,Ganesh Sriram,Melissa K. Harada,James C. Liao,Katrina M. Dipple	2009	16
17	Weighted gene co-expression network analysis identifies biomarkers in glycerol kinase deficient mice Molecular Genetics and Metabolism ·Nicole K. MacLennan,Jun Dong,Jason E. Aten,Steve Horvath,Lola Rahib,Loren Ornelas,Katrina M. Dipple,Edward R.B. McCabe	2009	27
18	Global metabolic effects of glycerol kinase overexpression in rat hepatoma cells Molecular Genetics and Metabolism ·Ganesh Sriram,Lola Rahib,Jian-Sen He,Allison E. Campos,Lilly S. Parr,James C. Liao,Katrina M. Dipple	2007	32
19	Glycerol kinase deficiency alters expression of genes involved in lipid metabolism, carbohydrate metabolism, and insulin signaling European Journal of Human Genetics ·Lola Rahib,Nicole K. MacLennan,Steve Horvath,James C. Liao,Katrina M. Dipple	2007	51
20	Targeted disruption of glycerol kinase gene in mice: expression analysis in liver shows alterations in network partners related to glycerol kinase activity Human Molecular Genetics ·Nicole K. MacLennan,Lola Rahib,Cynthia Shin,Zixing Fang,Steve Horvath,Jason Dean,James C. Liao,Edward R.B. McCabe,Katrina M. Dipple	2005	29

About Lola Rahib

Lola Rahib is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 7.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (22 papers), Cancer Genomics and Diagnostics (16 papers), Renal cell carcinoma treatment (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Global Cancer Incidence and Screening (4 papers), Adipose Tissue and Metabolism (4 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (2.2k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Lola Rahib has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Lynn M. Matrisian, Julie Fleshman, Benjamin D. Smith, Allison Rosenzweig, Mackenzie R. Wehner, Kevin T. Nead, Andrew Hendifar, Michael J. Pishvaian, Jonathan R. Brody and Subha Madhavan. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact